![1]()
News
More from DAPA-HF: Dapagliflozin quickly reduces heart failure events
February 22, 2021
Secondary analysis of DAPA-HF showed dapagliflozin significantly cut CV deaths or worsening heart failure within 28 days on treatment.
![1]()
News
Ivabradine knocks down heart rate, symptoms in POTS
February 19, 2021
The heart failure drug also may be helpful in treating similar symptoms in patients with long-hauler COVID-19, researchers say.
![1]()
News
FDA expands sacubitril/valsartan indication to embrace some HFpEF
February 17, 2021
The newly approved labeling for sacubitril/valsartan (Entresto) is simply for “chronic heart failure” but almost teasingly adds, “the benefits are most clearly evident” at below-normal LVEF.
![1]()
News
More Americans hospitalized, readmitted for heart failure
February 16, 2021
“We should be emphasizing the things we know work to reduce heart failure hospitalization, which is, number one, prevention.”
![1]()
News
ColCORONA: More questions than answers for colchicine in COVID-19
February 11, 2021
Millions of dollars and thousands of patients later, the phase 3 study highlights the challenges of COVID-19–related preprint studies without peer review.
News
Cardiac activity not uncommon after lifesaving measures stop
February 5, 2021
ECG and blood pressure monitoring identified resumption of cardiac activity in 14% of patients, all occurring in the 5 minutes after pulselessness.
![1]()
News
Complete PCI beats culprit-lesion-only PCI in STEMI patients with multivessel CAD
February 3, 2021
In patients who have a STEMI (ST elevation myocardial infarction) and are found to have multivessel coronary artery disease, does staged percutaneous coronary intervention (PCI) of nonculprit lesions improve cardiovascular death or MI?
News
Microthrombi, necrosis seen in COVID-19 hearts on autopsy
February 3, 2021
A new autopsy series shows microthrombi and focal necrosis in hearts of patients who died of COVID-19. The findings support use of anticoagulation, but best dosing remains unclear, researchers say.
![1]()
News
DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes
February 2, 2021
In patients who have diabetes with known coronary disease but without prior MI or stroke, what is the effect of dual-antiplatelet therapy (DAPT) with aspirin and ticagrelor on cardiovascular outcomes and bleeding events?
![1]()
News
Newer iPhones disable implanted defibrillators
February 1, 2021
Some newer smartphones are equipped with magnets sufficiently powerful to disable an implanted cardiac defibrillator.
